```

[Federal Register: June 11, 2010 (Volume 75, Number 112)]
[Notices]               
[Page 33308-33309]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr11jn10-74]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Medicare & Medicaid Services

[Document Identifier: CMS-10137 and CMS-10237]

 
Agency Information Collection Activities: Proposed Collection; 
Comment Request

AGENCY: Centers for Medicare & Medicaid Services.

    In compliance with the requirement of section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995, the Centers for Medicare & Medicaid 
Services (CMS) is publishing the following summary of proposed 
collections for public comment. Interested persons are invited to send 
comments regarding this burden estimate or any other aspect of this 
collection of information, including any of the following subjects: (1) 
The necessity and utility of the proposed information collection for 
the proper performance of the agency's functions; (2) the accuracy of 
the estimated burden; (3) ways to enhance the quality, utility, and 
clarity of the information to be collected; and (4) the use of 
automated collection techniques or other forms of information 
technology to minimize the information collection burden.
    1. Type of Information Collection Request: Revision of a currently 
approved collection; Title of Information Collection: Application for 
Prescription Drug Plans (PDP); Application for Medicare Advantage 
Prescription Drug (MA-PD)--CY 2012; Application for Cost Plans to Offer 
Qualified Prescription Drug Coverage; Application for Employer Group 
Waiver Plans to Offer Prescription Drug Coverage; Service Area 
Expansion Application for Prescription Drug Coverage; Use: Collection 
of this information is mandated under the Medicare Prescription Drug, 
Improvement, and Modernization Act of 2003 (MMA). The application 
requirements are codified in Subpart K 42 CFR Part 423 of entitled 
``Application Procedures and Contracts with PDP Sponsors.''
    Coverage for the prescription drug benefit is provided through 
contracted prescription drug plans (PDPs) or through Medicare Advantage 
(MA) plans that offer integrated prescription drug and health care 
coverage (MA-PD plans). Cost Plans that are regulated under Section 
1876 of the Social Security Act, and Employer Group Waiver Plans (EGWP) 
may also provide a Part D benefit. Organizations wishing to provide 
services under the Prescription Drug Benefit Program must complete an 
application, negotiate rates, and receive final approval from CMS. 
Existing Part D Sponsors may also expand their contracted service area 
by completing the Service Area Expansion (SAE) application. The 
collected information will be used by CMS to: (1) Ensure that 
applicants meet CMS requirements, (2) support the determination of 
contract awards. Form Number: CMS-10137 (OMB: 0938-0936); 
Frequency: Once; Affected Public: Business or other for-profits and 
not-for-profit institutions; Number of Respondents: 295; Total Annual 
Responses: 295; Total Annual Hours: 3,576 (For policy questions 
regarding this collection contact Marla Rothouse at 410-786-8063. For 
all other issues call 410-786-1326.)
    2. Type of Information Collection Request: Revision of a currently 
approved collection; Title of Information Collection: Part C Medicare 
Advantage Application and 1876 Cost Plan Expansion Application--CY 
2012; Use: The Balanced Budget Act of 1997 (BBA) established a new 
``Part C'' in the Medicare statute (sections 1851 through 1859 of the 
Social Security Act (the Act)) which provided for a Medicare+Choice 
(M+C) program. Under section 1851(a)(1) of the Act, every individual 
entitled to Medicare Part A and enrolled under Part B, except for most 
individuals with end-stage renal disease (ESRD), could elect to receive 
benefits either through the Original Medicare Program or an M+C plan, 
if one was offered where he or she lived. The Medicare Prescription 
Drug, Improvement, and Modernization Act of 2003 (MMA) established the 
Medicare Prescription Drug Benefit Program (Part D) and made revisions 
to the provisions of Medicare Part C, governing what is now called the 
Medicare Advantage (MA) program (formerly Medicare+Choice). 
Organizations wishing to provide healthcare services under MA and/or 
MA-PD plans must complete an application, file a bid, and receive final 
approval from CMS. Existing MA plans may expand their contracted area 
by completing the Service Area Expansion (SAE) application. Any current 
Cost Plan

[[Page 33309]]

Contractor that wants to expand its Medicare cost-based contract with 
CMS under Section 1876 of the Social Security Act, as amended by the 
Tax Equity and Fiscal Responsibility Act of 1982 (TEFRA) and subsequent 
legislation can complete the application. Form Number: CMS-10237 
(OMB: 0938-0935); Frequency: Yearly; Affected Public: Business 
or other for-profits and not-for-profit institutions; Number of 
Respondents: 355; Total Annual Responses: 355; Total Annual Hours: 
11,831 (For policy questions regarding this collection contact Letticia 
Ramsey at 410-786-5262. For all other issues call 410-786-1326.)
    To obtain copies of the supporting statement and any related forms 
for the proposed paperwork collections referenced above, access CMS' 
Web Site at http://www.cms.hhs.gov/PaperworkReductionActof1995, or E-
mail your request, including your address, phone number, OMB number, 
and CMS document identifier, to Paperwork@cms.hhs.gov, or call the 
Reports Clearance Office on (410) 786-1326.
    In commenting on the proposed information collections please 
reference the document identifier or OMB control number. To be assured 
consideration, comments and recommendations must be submitted in one of 
the following August 10, 2010:
    1. Electronically. You may submit your comments electronically to 
http://www.regulations.gov. Follow the instructions for ``Comment or 
Submission'' or ``More Search Options'' to find the information 
collection document(s) accepting comments.
    2. By regular mail. You may mail written comments to the following 
address: CMS, Office of Strategic Operations and Regulatory Affairs, 
Division of Regulations Development, Attention: Document Identifier/OMB 
Control Number, Room C4-26-05, 7500 Security Boulevard, Baltimore, 
Maryland 21244-1850.

    Dated: June 4, 2010.
Michelle Shortt,
Director, Regulations Development Group, Office of Strategic Operations 
and Regulatory Affairs.
[FR Doc. 2010-13898 Filed 6-10-10; 8:45 am]
BILLING CODE 4120-01-P
```